A small randomized trial demonstrated that novel maintenance immunotherapy(VIGIL) provided durable disease control in homologous repair proficient (HRP) ovarian cancer. Share on FacebookTweetFollow usSave Post navigation Researchers identify critical regulator of blood stem cell development. Childhood-onset Epilepsy accelerates brain aging.
Parvathy Sukumaran 
